title: Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in Children.
abstract: Urine drug screens (UDSs) are used to identify the presence of certain medications. One limitation of UDSs is the potential for false-positive results caused by cross-reactivity with other substances. Amphetamines have an extensive list of cross-reacting medications. The literature contains reports of false-positive amphetamine UDSs with multiple antidepressants and antipsychotics. We present 2 cases of presumed false-positive UDSs for amphetamines after ingestion of aripiprazole. Case 1 was a 16-month-old girl who accidently ingested 15 to 45 mg of aripiprazole. She was lethargic and ataxic at home with 1 episode of vomiting containing no identifiable tablets. She remained sluggish with periods of irritability and was admitted for observation. UDS on 2 consecutive days came back positive for amphetamines. Case 2 was of a 20-month-old girl who was brought into the hospital after accidental ingestion of an unknown quantity of her father's medications which included aripiprazole. UDS on the first day of admission came back positive only for amphetamines. Confirmatory testing with gas chromatography-mass spectrometry (GC-MS) on the blood and urine samples were also performed for both patients on presentation to detect amphetamines and were subsequently negative. Both patients returned to baseline and were discharged from the hospital. To our knowledge, these cases represent the first reports of false-positive amphetamine urine drug tests with aripiprazole. In both cases, aripiprazole was the drug with the highest likelihood of causing the positive amphetamine screen. The implications of these false-positives include the possibility of unnecessary treatment and monitoring of patients.
authors.affiliation: Department of Pharmacy, Hackensack University Medical Center, Hackensack, New Jersey, and Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, New Jersey;
authors.forename: Justin
authors.initials: J
authors.lastname: Kaplan
authors.affiliation: Department of Pharmacy, Hackensack University Medical Center, Hackensack, New Jersey, and Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, New Jersey; poojashah@hackensackumc.org.
authors.forename: Pooja
authors.initials: P
authors.lastname: Shah
authors.affiliation: Department of Pharmacy, Hackensack University Medical Center, Hackensack, New Jersey, and Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, New Jersey;
authors.forename: Brian
authors.initials: B
authors.lastname: Faley
authors.affiliation: Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Siegel
mesh_terms: D000061:Accidents, Home; D000662:Amphetamines / Q000652:urine*; D014150:Antipsychotic Agents / Q000506:poisoning* / Q000652:urine; D000068180:Aripiprazole / Q000506:poisoning* / Q000652:urine; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007223:Infant; D015813:Substance Abuse Detection / Q000379:methods*
chemical_list: D000662:Amphetamines; D014150:Antipsychotic Agents; D000068180:Aripiprazole